HTT and Huntington disease: Because aggregates of mutant huntingtin are pathogenic factors, and since genistein fulfills all the requirements for a potential drug to treat patients with metabolic neurodegenerative diseases for a long period, it is reasonable to propose further studies on the use of this isoflavone as an anti-HD drug.